In 2023, around 60 million adults in the United States received treatment or counseling for their mental health within the past year. Such treatment included inpatient or outpatient treatment or counseling, or the use of prescription medication. Anxiety and depression are two common reasons for seeking mental health treatment. Who most often receives mental health treatment? In the United States, women are almost twice as likely than men to have received mental health treatment in the past year, with around 21 percent of adult women receiving some form of mental health treatment in the past year, as of 2021. Considering age, those between 18 and 44 years are more likely to receive counseling or therapy than older adults, however older adults are more likely to take medication to treat their mental health issues. Furthermore, mental health treatment in general is far more common among white adults in the U.S. than among other races or ethnicities. In 2020, around 24.4 percent of white adults received some form of mental health treatment in the past year compared to 15.3 percent of black adults and 12.6 percent of Hispanics. Reasons for not receiving mental health treatment Although stigma surrounding mental health treatment has declined over the last few decades and access to such services has greatly improved, many people in the United States who want or need treatment for mental health issues still do not get it. For example, it is estimated that almost half of women with some form of mental illness did not receive any treatment in the past year, as of 2022. Sadly, the most common reason for U.S. adults to not receive mental health treatment is that they thought they could handle the problem without treatment. Other common reasons for not receiving mental health treatment include not knowing where to go for services or could not afford the costs.

In 2024, it was estimated that 28.2 percent of U.S. women received mental health treatment or counseling at some time in the past year. This statistic shows the percentage of U.S. women who received mental health treatment or counseling in the past year from 2002 to 2024.

Snapshot img

Online Therapy Services Market Size 2025-2029

The online therapy services market size is valued to increase USD 64.09 billion, at a CAGR of 53.9% from 2024 to 2029. Surging adoption of smartphones coupled with increased preference for online services will drive the online therapy services market.

Major Market Trends & Insights

North America dominated the market and accounted for a 42% growth during the forecast period.
By Type - Cognitive behavioral therapy segment was valued at USD 1.23 billion in 2023
By Application - Residential use segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 2.00 million
Market Future Opportunities: USD 64085.90 million
CAGR : 53.9%
North America: Largest market in 2023

Market Summary

The market encompasses the provision of mental health and wellness services through digital platforms. This sector is experiencing significant growth, driven by the surging adoption of smartphones and the increasing preference for online services. According to a recent study, the global teletherapy market is projected to reach a 25% adoption rate by 2025. However, the market's evolution is not without challenges. Privacy concerns related to patient mental health issues persist, necessitating stringent regulations and compliance measures. Core technologies, such as artificial intelligence and telecommunication, are revolutionizing online therapy services by enabling remote consultations, personalized treatment plans, and real-time monitoring.
Applications range from text-based therapy to virtual reality therapy and telepsychiatry. Service types include individual therapy, group therapy, and crisis intervention. Regional mentions include the United States, where teletherapy is gaining popularity, and Europe, where governments are investing in digital health initiatives. Despite these advancements, challenges such as reimbursement policies and licensing requirements continue to pose obstacles. Nevertheless, opportunities for growth abound, with increasing awareness of mental health issues and the convenience and accessibility of online therapy services.

What will be the Size of the Online Therapy Services Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Online Therapy Services Market Segmented and what are the key trends of market segmentation?

The online therapy services industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Type

  Cognitive behavioral therapy
  Psychodynamic therapy
  Personal centered therapy
  Solution-Focused Brief Therapy (SFBT)
  Dialectical Behavior Therapy (DBT)
  Mindfulness-Based Therapy


Application

  Residential use
  Commercial
  Educational Institutions
  Corporate/Employee Assistance Programs (EAPs)
  Non-Profit/Community Use
  Telehealth Integration


Industry

  Hospitals
  Clinics
  Ambulatory centers
  Others


Delivery Mode

  Synchronous
  Asynchronous


Technology Platform

  Mobile apps
  Web-based platforms
  Integrated wearable


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  Middle East and Africa

    UAE


  APAC

    China
    India
    Japan
    South Korea


  South America

    Brazil


  Rest of World (ROW)

By Type Insights

The cognitive behavioral therapy segment is estimated to witness significant growth during the forecast period.

Online therapy services have witnessed significant growth in recent years, with cognitive behavioral therapy (CBT) being one of the leading segments. CBT, an evidence-based approach to mental health treatment, has seen a surge in popularity due to digital platforms. Approximately 25% of online therapy service users opt for CBT, and this number is projected to increase by 30% in the upcoming years. The telehealth industry, which includes online therapy services, is expected to expand by 15% in the next five years. This growth is driven by the convenience and flexibility offered by these services. Patients can access therapy sessions at their own pace and schedule, making it an attractive alternative to traditional in-person therapy.

Telehealth platforms provide various features, such as appointment scheduling tools, patient portal access, addiction treatment options, depression treatment methods, and video conferencing software. These platforms also offer secure messaging systems, online CBT programs, data encryption protocols, billing and insurance services, and a network of licensed therapists. Additionally, remote patient monitoring, family therapy services, patient engagement tools, electronic health records, mental health

Mycetoma is a serious, destructive, disfiguring chronic granulomatous inflammatory disease affecting the subcutaneous tissues that spread to involve the skin, deep tissues and bone. The disease predominately affects the limbs, and extrapedal mycetoma is rarely reported. The reported extrapedal ones are characterised by high morbidity and mortality. This communication reports on 420 patients with extrapedal mycetoma seen and managed at the Mycetoma Research Centre (MRC), University of Khartoum, between January 1991 and December 2021. In this descriptive, cross-sectional, hospital-based study, the electronic records of all mycetoma-confirmed patients seen during the study period were carefully and meticulously reviewed. The confirmed patients with extrapedal mycetoma were included in this study. The study included 420 patients with extrapedal mycetoma, 298 (70.7%) had eumycetoma, and 122 (29.3%) had actinomycetoma. There were 343 male patients (81.7%) and 77 (18.3%) females, with a male-to-female ratio of 4:1. Their ages ranged between 1.5 and 95 years, with a median of 28 years. Most of the patients were students and farmers. The majority of patients were from El Gezira, North Kordofan, and the White Nile States. Mycetoma was painful in 21%, and a family history of mycetoma was recorded in 11.5% of patients. The buttocks (37.9%) and head and neck (16.9%) were affected most. Less frequently affected sites were the trunk and back (12%) each, abdominal and chest walls (4.5%) each and loin (1%). The prominent clinical presentation findings were multiple sinuses discharging grains (55%), massive swellings (46%), and lymphadenopathy (11.5%). Less commonly observed clinical findings were local hyperhidrosis (5.3%) and dilated tortuous veins close to mycetoma lesions (0.5%). The study showed that 204 patients (48.6%) had clinical improvement in terms of decreased lesion size and healing of sinuses following medical therapy. Sixty-six patients (15.7%) had no noticeable improvement. The lesion continued progressing despite treatment in 44 patients (10.5%). In the study, 118 patients were on regular follow-up, and in this group, a cure was documented in 25 patients (21.1%) with eumycetoma and 23 (19.4%) with actinomycetoma. Post-operative recurrence among eumycetoma patients was 40%, with a 1% mortality rate. The treatment outcome was unsatisfactory, characterised by a low cure rate, high recurrence (40%) and follow-up dropout (57%) rates. This emphasises the importance of early case detection and management, objective health education programmes and thorough patient counselling to urge people to seek treatment early and reduce dropouts.

This report presents findings from the third (wave 3) in a series of follow up reports to the 2017 Mental Health of Children and Young People (MHCYP) survey, conducted in 2022. The sample includes 2,866 of the children and young people who took part in the MHCYP 2017 survey. The mental health of children and young people aged 7 to 24 years living in England in 2022 is examined, as well as their household circumstances, and their experiences of education, employment and services and of life in their families and communities. Comparisons are made with 2017, 2020 (wave 1) and 2021 (wave 2), where possible, to monitor changes over time.

Wearable Physiotherapy Market Outlook

The global wearable physiotherapy market size was valued at approximately $1.5 billion in 2023 and is projected to reach around $4.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.1% during the forecast period. This robust expansion is driven by several factors, including advancements in wearable technology, increasing incidence of chronic diseases, and a growing awareness of preventative healthcare measures. The integration of IoT and AI in wearable devices has revolutionized the physiotherapy sector, providing real-time data and personalized treatment plans, which are significant growth propellers for this market.

One major growth factor for the wearable physiotherapy market is the rising prevalence of chronic conditions such as arthritis, cardiovascular diseases, and neurological disorders. These medical conditions often require long-term physiotherapy, which can be effectively managed through wearable devices that offer continuous monitoring and treatment. The aging global population is another critical driver, as older adults are more prone to musculoskeletal and cardiovascular issues that necessitate ongoing physiotherapy. Wearable physiotherapy devices are seen as a convenient and efficient solution for this demographic, reducing the need for frequent clinic visits.

Technological advancements are also playing a crucial role in the growth of this market. The development of sophisticated wearable devices equipped with sensors, actuators, and advanced software algorithms has made it possible to monitor and treat patients in real-time. These devices can track a wide range of physiological parameters, provide biofeedback, and even deliver therapeutic interventions. The increasing integration of artificial intelligence and machine learning in these devices allows for more personalized and effective treatment plans, enhancing patient outcomes and fueling market growth.

The growing awareness and adoption of preventive healthcare measures are further boosting the market. Consumers are becoming more health-conscious and are increasingly investing in wearable devices that can help maintain and improve their physical well-being. These devices are not only used for rehabilitation purposes but also for general fitness and preventive care. The convenience and accessibility offered by wearable physiotherapy devices make them an attractive option for a wide range of users, from professional athletes to individuals recovering from surgery or injury. This trend towards proactive health management is expected to continue driving the market forward.

From a regional perspective, North America currently dominates the wearable physiotherapy market, primarily due to the high adoption rate of advanced healthcare technologies, a well-established healthcare infrastructure, and significant R&D investments. Europe follows closely, driven by similar factors. The Asia Pacific region is expected to witness the highest growth rate during the forecast period, attributed to increasing healthcare expenditure, rising awareness about physiotherapy, and the rapid adoption of wearable technology. Emerging economies in Latin America and the Middle East & Africa are also expected to contribute to the market growth, albeit at a slower pace.

Product Type Analysis

The wearable physiotherapy market is segmented by product type into wearable sensors, wearable therapeutic devices, and wearable rehabilitation devices. Wearable sensors are devices that can measure and monitor various physiological parameters such as heart rate, body temperature, and muscle activity. These sensors are crucial for providing real-time data, which can be used to adjust treatment plans and improve patient outcomes. The demand for wearable sensors is expected to grow significantly as they become more integrated with advanced software platforms capable of providing detailed analytics and insights. Companies are continuously innovating to develop sensors that are more accurate, reliable, and user-friendly.

Wearable therapeutic devices are designed to deliver treatment directly to the patient. These devices can administer electrical stimulation, heat therapy, or other therapeutic modalities to help manage pain and improve mobility. The convenience and effectiveness of these devices make them popular among patients and healthcare providers. Technological advancements are enabling the development of more sophisticated wearable therapeutic devices that can be customized to meet the individual needs of patients. This segment is expected to witness substantial growth a

In 2023, there were 3,811 deaths in Canada from suicide. This was a decrease from the year before in which 4,216 people died from suicide. The death rate from suicide in Canada in 2023 was 9.5 per 100,000 population, the lowest rate seen over the past two decades. Warning signs of suicide can include suicidal ideation, withdrawal from family and friends, increased alcohol or drug use, dramatic mood swings, and impulsive or reckless behavior. Suicide by age Although suicide is more common among some age groups than others, mental health issues and suicide impact people of all ages. Of the 3,769 suicide deaths recorded in Canada in 2021, 344 were among those aged 30 to 34 years. This was the highest number of suicides among all age groups. However, those aged 50 to 54 years had the highest death rate from suicide at that time with 13.4 deaths per 100,000 population. The age group with the second highest suicide death rate was those aged 30 to 39 years, with a rate of 12.8 deaths per 100,000 population. The mental health status of Canadians Most people who resort to suicide suffer from mental health issues, which is one reason why open discussion around mental health and access to mental health treatment are so important. In 2021, almost 12 percent of Canadians stated that their mental health was just fair or poor. The share of Canadians reporting fair or poor mental health has increased in recent years and hit a high in 2021, perhaps in part due to the COVID-19 pandemic. Furthermore, almost 10 percent of Canadians now report that they have been diagnosed with a mood disorder such as depression, bipolar disorder, mania, or dysthymia. Depression is one of the most common mental health issues, but is also often easily treated through therapy, medication, lifestyle changes, or a combination of these.

In 2024, some 8.2 percent of adults in the United States reported experiencing a major depressive episode in the past year. However, among those aged 18 to 25 years, some 15.9 percent reported a major depressive episode. Depression is one of the most common mental health disorders in the United States and in severe cases can seriously affect one’s ability to function. Depression among men and women Although depression can affect anyone, women are more likely to report experiencing a major depressive episode than men. In 2021, around 10 percent of women in the United States stated they had a major depressive episode in the past year, compared to six percent of men. Women aged 18 to 20 were the most likely to suffer from a major depressive episode with up to 21 percent reporting such an episode in 2023. In comparison, just 12 percent of men aged 18 to 20 said they had a major depressive episode at that time. Among men, those aged 21 to 25 had the highest prevalence of major depression. Treatment for depression Fortunately, depression is treatable, and the vast majority of people who receive treatment benefit from it. Depression is most commonly treated with medication, talk therapy, or a combination of both. In 2022, around 12.8 million people in the United States received treatment for a major depressive episode. The most common type of professionals seen for such treatment were general practitioners or family doctors and psychiatrists or psychotherapists. Among U.S. youths who are treated for a major depressive disorder, very few are treated using only prescription medication. Instead, it is much more common for youth to see or talk to a health professional only, or to see a health professional and use prescription medication.

In 2023, there were over 33 thousand practicing physiotherapists employed in the health sector in the United Kingdom. This is an increase of almost 70 percent from the year 2000, when there were around 19.4 thousand physiotherapists employed in the country. Frequency of visiting physios in the UK   As of 2018, there were 33 percent of individuals in the UK who were living with a long-standing limiting health condition or illness. This was higher than the share of those in other similar sized Western European countries such as Spain and France, but below 40 percent of the German population living with a long-term health condition. The same year, five percent of people in the UK said they visited a physical or occupational therapist at least three times a year. Overall, 19 percent of those in the UK visited a physical or occupation therapist at least once a year.  Other healthcare positions also increasing Across the same time period, the number of physicians in the UK has increased by over 86 percent resulting in approximately 215 thousand employed physicians in 2022. The number of practicing nurses in the UK has also increased, but at a lot lower rate, to approximately 585.3 thousand nurses in 2022. 

SARS-CoV-2 related oral manifestation latency time, duration, and therapy.